NCT04765501Completed
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Impact Questionnaire
Source: ClinicalTrials.gov · Last updated 8 Apr 2025
Brief summary (registry, in English)
The purpose of this study was to investigate cultural adaptation, reliability and validity of the Turkish version of the Headache Impact Questionnaire (HIQ).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 102 (actual)
- First submitted
- 19 Feb 2021
- Start date
- 1 Nov 2022
- Primary completion date
- 1 Sept 2023
- Lead sponsor
- Gazi University
- Diseases
- Migraine
- NCT number
- NCT04765501
What you commit to
- Study type: Observational
- Participants enrolled: 102
- From 1 Nov 2022 to the primary completion date, 1 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a cognitive and neurological disorders.
Who the study is looking for
- Diagnosed with any type of headache,
- Have a chronic headache.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Halime ARIKAN Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.